New hope for tough lung cancer: first patients test novel IV treatment
NCT ID NCT06922539
Summary
This early-stage trial is testing a new intravenous drug called ST-001 for people with small cell lung cancer that has returned or stopped responding to standard treatments. The main goals are to find the highest safe dose and understand how the drug moves through the body. Researchers will also watch to see if the treatment helps shrink tumors or slow the cancer's growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Southern California
RECRUITINGLos Angles, California, 90007, United States
Conditions
Explore the condition pages connected to this study.